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Abstract
This work describes the synthesis and use of the chelator lipid, nitrilotriacetic acid ditetradecylamine (NTA-DTDA). This
lipid is readily dispersed in aqueous media, both alone and when mixed with carrier lipids like dimyristoylphosphatidylcho-
line (DMPC). Fluorescence microscopic examination of membranes deposited from NTA-DTDA-containing liposomes
shows that NTA-DTDA mixes uniformly with the carrier lipid, and does not phase separate. NTA-DTDA-membranes
deposited onto the sensing surface of IAsys biosensor cuvettes show good stability, permitting use of the biosensor to study
protein interactions. Hexahistidine-tagged proteins including recombinant forms of the extracellular regions of murine B7.1
(B7.1-6H) and of the human erythropoietin receptor (EPOR-6H) bind to NTA-DTDA-membranes; the stability of binding
is dependent on both protein concentration, and density of NTA-DTDA. Kinetic measurements show that high stability of
anchored proteins (t1=2V10^20 h, apparent KdV1 nM) can be achieved using membranes containing 25 mol% NTA-DTDA,
but low levels of bound protein (6 200 arc seconds). The system is used to study the interaction of human EPO with the
EPOR anchored onto NTA-DTDA-membranes. In addition to the biological applications reported recently, the results show
that NTA-DTDA can be a useful reagent in the study of receptor^ligand interactions. ß 2001 Elsevier Science B.V. All
rights reserved.
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1. Introduction
Metal chelator lipids recently have attracted con-
siderable interest for protein crystallisation and for
biosensor applications in the study of protein^pro-
tein interactions. For example, chelator lipids have
been used for two-dimensional crystallisation of his-
tidine-tagged proteins including HIV-1 reverse tran-
scriptase and RNA polymerase I [1^4], and the re-
versible binding of hexahistidine peptides and tagged
proteins to membranes [5^10]. Analogous to the
0005-2736 / 01 / $ ^ see front matter ß 2001 Elsevier Science B.V. All rights reserved.
PII: S 0 0 0 5 - 2 7 3 6 ( 0 1 ) 0 0 3 4 4 - 3
Abbreviations: NTA-DTDA, nitrilotriacetic acid ditetradecyl-
amine; POPC, Palmitoyloleoylphosphatidylcholine; DMPC, di-
myristoylphosphatidylcholine; NTA-DODA, nitrilotriacetic acid
dioctadecylamine; Streptavidin^FITC, £uorescein isothiocyanate-
conjugated streptavidin; EPO, erythropoietin; EPOR, erythro-
poietin receptor
* Corresponding author. Fax: +61-2-6125-0313.
E-mail address: joseph.altin@anu.edu.au (Joseph G. Altin).
BBAMEM 78113 9-7-01
Biochimica et Biophysica Acta 1513 (2001) 131^148
www.bba-direct.com
binding of hexahistidine-tagged proteins during
Ni2-NTA chromatography [11], lipids with head-
groups like nitrilotriacetic acid (NTA) can form re-
versible chelating linkages with proteins bearing an
appropriate metal a⁄nity tag, thereby making the
lipids well-suited as protein anchors in membrane
systems. Since recombinant proteins such as the
extracellular domains of cell surface receptors can
readily be engineered to possess a metal a⁄nity tag
(e.g., hexahistidine), and chelator lipids can be used
to conveniently anchor the tagged receptors in the
correct orientation onto model membranes, the lipids
make ideal components in biosensor applications for
the study of receptor^ligand interactions in a mem-
brane environment. Analogous to proteins possessing
a glycosyl-phosphatidylinositol anchor [12], proteins
anchored via chelator lipids are free to move and to
interact laterally on the membrane; this attribute
may allow spontaneous dimerisation and/or multi-
meric interaction events to occur, and hence poten-
tially mimic phenomena seen on the surface of cells
[13^16]. The facilitation of co-operative binding
events may better approximate molecular interac-
tions as they would occur under physiological con-
ditions [17,18], and may permit biosensors to mea-
sure interactions not readily detectable when one of
the interacting species is immobilised by covalent
techniques which normally preclude lateral protein
mobility and oligomerisation.
In this paper we describe the synthesis of the che-
lator lipid, nitrilotriacetic acid ditetradecylamine
(NTA-DTDA), which possesses an NTA-headgroup
attached via a nitrogen to two saturated 14-carbon
chains. This lipid is stable under laboratory condi-
tions and can be dispersed in aqueous bu¡ers to
form a suspension, either alone, or as a mixture
with a carrier phospholipid such as dimyristoylphos-
phatidylcholine (DMPC). In this work we use £uo-
rescence microscopy to show that NTA-DTDA binds
hexahistidine tagged proteins, and that it mixes uni-
formly with the carrier lipid. An IAsys biosensor is
used to study the interaction of two hexahistidine-
tagged proteins with NTA-DTDA-containing mem-
branes, and the interaction of the human haemato-
poietic growth factor erythropoietin (EPO) with a
recombinant form of the extracellular region of the
EPO receptor (EPOR) anchored onto membranes via
NTA-DTDA. Conditions for stable binding of hexa-
histidine-tagged proteins to NTA-DTDA mem-
branes are established, and the study shows that
the chelator lipid can be used to study receptor^
ligand interactions in a model membrane system.
Other applications of the chelator lipid are dis-
cussed.
2. Materials and methods
2.1. Reagents
Analytical grade reagents were used in all experi-
ments. Dimyristoyl-phosphatidylcholine (DMPC),
and K-palmitoyl-L-oleoyl-phosphatidylcholine
(POPC), were obtained from Sigma-Aldrich (Castle
Hill, NSW, Australia). Biotinylated-(K-palmitoyl-
L-oleoyl-phosphatidylethanolamine) (B-POPE) was
obtained from Molecular Probes (Oregon, USA);
streptavidin and restriction enzymes (Fermentas)
were obtained from Progen Industries (Darra, Qld,
Australia). Sulfo-NHS-LC-biotin was obtained from
Pierce (Rockford, IL, USA). Fluorescein isothiocya-
nate (FITC)-conjugated streptavidin (streptavidin^
FITC) was obtained from Amersham (UK). IAsys
biosensor dual-cell cuvettes were purchased from Af-
¢nity Sensors (Bar Hill, Cambridge, UK). TNMF
medium for the growth of SF9 insect cells was pur-
chased from Sigma, and Express Five Medium for
protein expression in insect High-5 cells was obtained
from Gibco (Life Technologies, Melbourne, Austra-
lia). Foetal calf serum (FCS) was from Trace Scien-
ti¢c (Noble Park, Vic., Australia).
2.2. Recombinant proteins
Recombinant human erythropoietin, namely Eprex
(Janssen-Cilag) was obtained from the Hospital
Pharmacy (Royal Canberra Hospital). Recombinant
forms of the extracellular regions of the murine
T-cell costimulatory molecules B7.1 (CD80) and the
extracellular region of the human erythropoietin re-
ceptor (EPOR), each with a hexahistidine (6His) tag
at the carboxyl terminal end of the protein, and de-
noted B7.1-6H and EPOR-6H, respectively, were
produced using the baculovirus expression system
as described previously [19]. Brie£y, genes encoding
the extracellular domains of murine B7.1 and human
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EPOR were ampli¢ed by polymerase chain reaction
(PCR), and the sequences for 6His tags were incor-
porated into the end of each gene (corresponding to
the carboxyl terminal of the protein) by PCR using
primers containing the sequence of the tag. The con-
structs were then separately ligated into the pVL1393
plasmid baculovirus transfer vector and used to
transform Escherichia coli. Appropriate transform-
ants were selected, and recombinant pVL1393 plas-
mids from these transformants were co-transfected
with the baculovirus AcMNPV into SF9 insect cells.
Cells infected with virus which had the pVL1393
plasmid incorporated into the viral genome were se-
lected by plaque assays, further ampli¢ed and these
viral stocks were used to infect High-5 insect cells
grown in Express-5 medium. Recombinant proteins
were puri¢ed from the supernatants of recombinant
virus infected High-5 cells by Ni2-NTA a⁄nity
chromatography (using Ni2-NTA Super£ow, from
Qiagen, Cifton Hill, Vic., Australia) followed by size
exclusion gel ¢ltration on FPLC (Pharmacia Biotech,
Uppsala, Sweden) using phosphate-bu¡ered saline
containing 150 mM sodium chloride and 10 mM
sodium phosphate (pH 7.4) (PBS) as the running
bu¡er, and a Superdex-75 HR 10/30 column. Each
protein eluted as a monomer with the apparent mo-
lecular mass on gel ¢ltration being V43 kDa for
B7.1-6H, and V30 kDa for EPOR-6H; the ¢nal
purity of each protein was s 95% as judged by so-
dium dodecyl sulfate^polyacrylamide gel electropho-
resis analysis. For some experiments recombinant
proteins were biotinylated by reacting with sulfo-
LC-biotin (Pierce) as described previously [19]. The
proteins were routinely stored at 320‡C in PBS at a
concentration of 0.2^0.6 mg/ml, and then thawed at
37‡C and vortexed gently prior to use in each experi-
ment.
2.3. Synthesis of NTA-DTDA
(R)-NK,NK-Bis[carboxymethyl]-NO-[(ditetradecyla-
mino)succinyl]lysine 7, which is the chelator lipid re-
ferred to as ditetradecylamine (NTA-DTDA), was
prepared as shown in Scheme 1, by adapting the
procedure reported previously for the synthesis of
the corresponding dioctadecylamide [5]. 1-Bromotet-
radecane 1 and reagents and solvents were pur-
chased from Sigma-Aldrich. The bromide 1 was
treated with ammonia, at 90‡C under pressure, to
give the amine 2 [(37%); 1H-NMR (CDCl3) N 0.89
(6H, t, J = 7 Hz), 1.24 (44H, m), 1.81 (4H, m), 2.88
(4H, m); ESMS m/z 410 (M+H)]. Reaction of the
amine 2 with succinic anhydride in the presence of
triethylamine a¡orded the succinate 3 [(42%); 1H-
NMR (CDCl3) d 0.88 (6H, t, J = 7 Hz), 1.26 (44H,
m), 1.54 (4H, m), 2.68 (4H, s), 3.23 (4H, m); ESMS
m/z 510 (M+H)]. The acid 3 was coupled with
N-hydroxysuccinimide, using dicyclohexylcarbodi-
imide and 4-dimethylaminopyridine, to give 4
[(76%); ESMS m/z 607 (M+H)]. (R)-NK-Boc-lysine
was treated with trimethylchlorosilane in the pres-
Scheme 1.
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ence of triethylamine, and then with the succinimide
4 to give 5 [(69%); 1H-NMR (CDCl3) N 0.88 (6H, t,
J = 7 Hz), 1.26 (44H, m), 1.43 (9H, s), 1.49 (4H, m),
1.75 (4H, m), 2.52 (2H, m), 2.65 (4H, m), 3.24 (6H,
m), 4.20 (1H, m); ESMS m/z 738 (M+H)], from
which the Boc protecting group was removed by
treatment with tri£uoroacetic acid. The free amino
acid 6 [(93%); 1H-NMR (CDCl3) N 0.88 (6H, t,
J = 7.5 Hz), 1.26 (44H, m), 1.48 (4H, m), 1.75 (4H,
m), 2.50 (2H, m), 2.65 (4H, m), 3.20 (6H, s), 3.60
(1H, m); ESMS m/z 638 (M+H)] reacted with bro-
moacetic acid in the presence of triethylamine to give
the tricarboxylic acid 7 [(14%); 1H-NMR (CDCl3/
CD3OD/TFA-80:19:1) N 0.79 (6H, t, J = 7 Hz),
1.16 (44H, m), 1.40 (4H, m), 1.76 (4H, m), 2.40
(2H, m), 2.56 (4H, m), 3.14 (7H, m), 3.52 (4H, m);
ESMS m/z 754 (M+H)].
2.4. Preparation of liposome suspensions
Liposomes were prepared from carrier lipids
(either DMPC or POPC) or mixtures of these plus
the indicated proportion of NTA-DTDA or B-POPE
essentially as described [19]. Desiccated mixtures of
the carrier lipid and the indicated mole fraction of
NTA-DTDA (or B-POPE) were suspended to a ¢nal
concentration of 1 mM total lipid in PBS containing
also 10 mM MgCl2 and 100 WM NiCl2 (PBS-Mg-Ni),
by sonication using a TOSCO 100W ultrasonic
disintegrator at maximum amplitude for two cycles
of 1 min each. Control liposomes containing DMPC
but without either NTA-DTDA or B-POPE were
routinely prepared to contain 5 mol% POPC
(DMPC/POPC, molar ratio 20:1) to promote bind-
ing and fusion of the liposomes to the sensing surface
of IAsys biosensor cuvettes (see below). For some
experiments the lipids were pre-mixed from stock so-
lutions of lipid (10 mg/ml) in either ethanol or etha-
nol/chloroform (1:2) in the appropriate proportions,
and then desiccated by evaporating the solvent under
a stream of dry nitrogen and drying the lipids in a
speed vac for V1 h, before adding PBS-Mg-Ni to
give a ¢nal lipid concentration of 1 mM and sonicat-
ing (as above). The temperature of lipid mixtures did
not exceed 50‡C during sonication. Liposome sus-
pensions were either used immediately for deposition
of lipid bilayers either on glass microscope slides or
on the sensing surface of IAsys biosensor cuvettes, or
were stored frozen at 320‡C and then re-sonicated
brie£y before use in membrane depositions.
2.5. Fluorescence microscopy of membranes deposited
on glass slides
Clean glass Objekttrager microscope slides (from
HD Scienti¢c Supplies, Sydney, Australia) that had
been lightly £amed under a bunsen £ame for about
1 min and then cooled to V30‡C were used as pla-
nar membrane supports. Planar membranes were de-
posited from liposomes [20,21] by adding a suspen-
sion of liposomes to 0.2-mm deep chambers formed
on the slides using perforated Scotch Brand 3M ad-
hesive tape, and then washed several times with PBS
and distilled water before carefully immersing the
slides into separate 50 ml Falcon tubes ¢lled with
PBS and incubating for either 30 min or overnight
at 30‡C, as indicated. After the incubation the mem-
branes were removed from the tubes, incubated with
0.5 WM of biotinylated B7.1-6H in PBS for 15 min at
room temperature, washed and incubated for 5 min
with PBS containing 0.5% bovine serum albumin (to
block nonspeci¢c binding), and then stained by in-
cubating for 15 min with 1:15 dilution of streptavi-
din^FITC in PBS containing 1% bovine serum albu-
min. Care was taken to ensure that the membranes
were always kept in aqueous media and never di-
rectly exposed to air throughout the procedure.
Each chamber was then sealed with a glass coverslip
and the membrane £uorescence visualised by confo-
cal laser scanning microscopy. Membrane £uores-
cence was assessed at 520 nm using a BioRad
MRC-500 Laser Scanning Confocal Imaging System,
consisting of a Nikon confocal £uorescence micro-
scope (U20 objective), with a BioRad UV-laser scan-
ner (BioRad) and an Ion Laser Technology laser
head (model 5425, BioRad) with an argon ion laser.
The image was acquired by Kalman averaging of
four successive laser scans, stored and analysed using
Image Processor PC software (BioRad) and pro-
cessed using NIH Image 1.61 software.
2.6. Membrane deposition on IAsys biosensor cuvettes
Previous studies report deposition of membranes
on hydrophobic surfaces of BIAcore biosensors
[22^24]. Preliminary experiments indicated that dep-
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osition of lipid membranes onto the surface of hy-
drophobic IAsys cuvettes, either from organic sol-
vents or from a suspension of liposomes, did not
always yield a consistent level of deposition, espe-
cially after several cycles of membrane deposition
and removal from the cuvette. In view of the cost
of IAsys cuvettes several di¡erent regeneration strat-
egies were tested to see if reproducible levels of mem-
brane deposition could be achieved on the same cu-
vette; these included: extensive separate washings
with ethanol, distilled water, and/or washing with
di¡erent concentrations of NaOH and HCl. The
most consistent results were obtained by removing
the lipid membranes from the cuvette with 4^5
washes of either methanol or ethanol, then rinsing
the cuvette with distilled water, followed by three
washes with 2 M NaOH, and then again rinsing
with water but followed by three washes with 2 M
HCl and four washes with 20 mM HCl. The NaOH
and HCl washes were usually carried out slowly over
1^2 min to allow time for thorough cleaning of the
surface, whereas the rinses with water were per-
formed more quickly (usually over 30 s). As well as
removing any lipids from previous depositions, this
treatment completely removed the hydrophobic sur-
face of the cuvette, producing a highly hydrophilic
surface which permitted bilayer membranes to be
deposited onto the surface from liposomes.
Membranes were deposited onto the IAsys sensing
surface from liposomes as follows: cuvettes were
cleaned (as above) and after the ¢nal 20 mM HCl
wash the cuvette was aspirated, leaving V15 Wl of 20
mM HCl in each cell. 50 Wl of the appropriate lipo-
some suspension was then added to each cell and
incubated for 5^10 min (30‡C) to allow binding
and fusion of liposomes with the sensing surface.
The assumption that the added liposomes fuse with
the surface is supported by: (1) the knowledge that
phosphatidylcholine-containing liposomes readily
fuse with hydrophilic surfaces to form stable planar
bilayers [20]; (2) by the fact that membranes depos-
ited from NTA-DTDA-containing lipid suspensions
exhibit uniform surface £uorescence after binding of
hexahistidine-tagged protein and staining with strept-
avidin^FITC (see Fig. 1); and (3) by our studies
showing that the biosensor signal due to lipid bind-
ing (V1750 arc seconds (arc s), see Fig. 2) is essen-
tially identical to that reported previously, where it
was shown using ellipsometric techniques that the
interaction of liposomes with a number of di¡erent
silicon substrates (silicon nitride is used in IAsys cu-
vettes) gives lipid depositions consistent with the for-
mation of bilayers [23]. It was noted that the slight
acidi¢cation of the liposomes upon their addition to
the 15 Wl of 20 mM HCl that remained in each cell
after aspiration promoted binding and fusion of the
liposomes with the surface, as judged by the rate and
extent of lipid binding monitored with the biosensor.
Membrane deposition, as re£ected by a plateauing of
lipid binding to the surface, was usually complete
within 5^10 min. The cuvette was then washed four
times with PBS and four times with either distilled
water or 10 mM NaOH (over 2^3 min) to remove
loosely bound/unfused liposomes. The contents of
each cell was then replaced by washing 4^5 times
with PBS, and the instrument was then allowed to
equilibrate for 5^10 min to achieve a stable baseline
before using in experiments to study the interaction
of proteins. The refractive index change following the
deposition of a bilayer was typically V1750 arc s for
membranes consisting of DMPC and 10% NTA-
DTDA. Biosensor cuvettes with a bilayer membrane
deposited in this way always gave the expected sym-
metrical resonance scan indicating that a uniform
coverage of the membrane on the sensing surface
was achieved, and that a reliable signal was being
generated by the instrument.
2.7. Assaying protein binding with the IAsys biosensor
An IAsys resonant mirror biosensor (A⁄nity Sen-
sors, Cambridge, UK) with a dual-cell hydrophobic
cuvette but with a hydrophilic sensing surface pre-
pared as above was used to determine the kinetic
constants and a⁄nities of the binding of hexahisti-
dine-tagged proteins to either control membranes
(i.e., membranes containing only DMPC) or mem-
branes containing DPMC plus either B-POPE or
NTA-DTDA in the proportions indicated. Control
experiments to assess the binding of hexahistidine-
tagged proteins to NTA-DTDA-containing mem-
branes in the presence of 10 mM EDTA (or without
Ni2 loading) indicated that under these conditions
there was very little if any binding of the proteins,
and that binding was indistinguishable from that
seen with membranes containing 95 mol% DMPC
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and 5 mol% POPC. Binding experiments were there-
fore routinely carried out using the indicated test
membrane in one cell and a control membrane con-
taining 95 mol% DMPC and 5 mol% POPC (instead
of using EDTA) in the other cell, in order to avoid
any potential interference of the EDTA on the con-
trol binding of soluble ligand in experiments such as
those described for the interaction of membrane-an-
chored EPOR-6H with soluble EPO. All binding ex-
periments were performed in PBS at a temperature of
30‡C. The contents of each cell were stirred contin-
uously by the aid of a propeller (stir rate set to 80 per
min). Binding to the sensing surface in each cell was
measured at 2-s intervals, and the readout from the
biosensor was in units of arc s. Proteins were added
to the test cell from stock solutions made in PBS to
give the appropriate ¢nal protein concentration.
Binding of proteins to membranes or to membrane-
anchored EPO receptor was monitored for the time
indicated; the contents of each cell were then re-
placed by washing four times with PBS, before mon-
itoring the dissociation phase for the time indicated.
Analyses of data obtained from the binding of pro-
teins to the test membrane (in the test cell), were
carried out only after subtracting the signal of the
control cell from that of the test cell, to remove the
bulk refractive index change and any non-speci¢c
binding. The Fast Fit program supplied by A⁄nity
Sensors was used to evaluate the kinetic constants
(see below).
2.8. Evaluation of kinetic constants
The IAsys biosensor was provided with a digital
DECpc 450D2LP computer. Data obtained with the
biosensor were transferred directly to the Fast Fit
program (A⁄nity Sensors). As detailed previously
[25,26], this program uses iterative curve ¢tting to
derive the observed rate constant and the maximum
response at equilibrium due to ligand binding at the
particular ligand concentration. Pro¢les for the bind-
ing of the hexahistidine-tagged proteins B7.1-6H and
EPOR-6H to membranes containing NTA-DTDA,
or the binding of EPO to membranes containing
NTA-DTDA and anchored EPOR, were analysed
using the Fast Fit program. kobs was calculated
from a single exponential ¢t of the binding phase,
and kon was calculated from the gradient of the
plot of kobs versus protein concentration which ap-
proximated a straight line. koff was determined either
from the y-intercept of the plot of kobs versus protein
concentration, or directly from exponential ¢ts of the
dissociation phase, as indicated. When a single expo-
nential dissociation did not adequately ¢t the disso-
ciation data, double exponential ¢tting was used to
calculate the fast and slow koff components. The dis-
sociation constant was determined using the expres-
sion Kd = koff /kon, or by Scatchard analysis, as indi-
cated. Other details for the determination of kinetic
constants have been described previously [25,26].
3. Results
3.1. Distribution of NTA-DTDA in lipid membranes
and binding of tagged proteins
To be useful as a membrane anchor for receptors
on supported lipid membranes it is essential that the
NTA-DTDA be miscible with carrier lipids like
phosphatidylcholine, and does not phase-separate.
Preliminary studies indicated that NTA-DTDA can
be dispersed in aqueous media (such as PBS) up to
concentrations of around 1^2 mM by sonicating for
2^3 min, provided that the medium contained an
equimolar concentration of divalent metal cations
such as Ni2 or Zn2, and around 150 mM NaCl.
The mixing properties of the NTA-DTDA were
further examined by sonicating mixtures of NTA-
DTDA and dimyristoylphosphatidylcholine (DMPC),
and using the resulting liposome suspension to form
supported lipid bilayers suitable for analysis by £uo-
rescence confocal microscopy. Bilayer membranes
were deposited onto glass microscope slides from
suspensions of DMPC (used as control) or DMPC
plus NTA-DTDA, and were incubated for 30 min at
30‡C (i.e., at a temperature above the Tm of the
carrier lipid in the membrane, Tm V24‡C for
DMPC). After this incubation the bilayers were in-
cubated at room temperature for 15 min with 0.5 WM
biotinylated-B7.1-6H (B-B7.1-6H), before washing
o¡ unbound protein and staining with streptavidin^
FITC. As shown in Fig. 1A, DMPC bilayers stained
very weakly, indicating that little if any biotinylated
B-B7.1-6H binds to these membranes (Fig. 1A). In
contrast, NTA-DTDA-containing bilayers stained
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signi¢cantly above background for membranes con-
taining DMPC and 2 mol% NTA-DTDA (Fig. 1B)
and more strongly with membranes containing
DMPC and 25 mol% NTA-DTDA (Fig. 1C). Impor-
tantly, no heterogeneities in the £uorescence could be
detected to the limit of resolution (V0.1 Wm) for
images of membranes containing these ratios of
DMPC to NTA-DTDA. Similar results were ob-
tained using POPC (Tm 32‡C) instead of DMPC
as the carrier lipid, and also when the membranes
were pre-incubated overnight (instead of 30 min) at
30‡C (not shown). The results indicate that the NTA-
DTDA can be used to anchor hexahistidine-tagged
proteins, and that at this resolution the distribution
of the NTA-DTDA in the membrane is uniform.
3.2. NTA-DTDA membrane studies with the IAsys
biosensor
Biosensor studies of protein interactions on lipid
membranes can be performed with the IAsys biosen-
sor using a hydrophobic cuvette. Membrane deposi-
tions on IAsys hydrophobic cuvettes were initially
carried out by incubating the sensing surface with a
mixture of DMPC and NTA-DTDA dissolved in
isopropanol/chloroform (2:1) for 10 min, before add-
ing PBS to form a supported membrane by self-as-
sembly. Although initial levels of lipid binding to the
IAsys surface (V850 arc s) were consistent with pre-
vious reports for deposition of a monolayer on the
IAsys, we found that lipid deposition by this proce-
dure was not always reproducible, especially after
several cycles of membrane deposition and removal.
The variations were attributed to incomplete regen-
eration of the sensing surface after each cycle of
membrane deposition and removal. In particular,
we noted that the hydrophobicity of the cuvette sur-
face deteriorated signi¢cantly with each cycle, even
when the surface was washed according to the man-
ufacturer’s instructions. Therefore, an alternative
methanol-NaOH-HCl wash procedure was employed
(see methods) which converted the hydrophobic sur-
face into a highly hydrophilic one, facilitating surface
regeneration and permitting rapid and reproducible
membrane depositions from liposomes. As shown in
Fig. 2, the addition of liposomes containing DMPC
and either biotinylated-phosphatidylethanolamine
(B-POPE, 2 mol%, dotted line), or NTA-DTDA
(10 mol%, solid line), to separate wells of an IAsys
2-well cuvette, results in a rapid saturable binding of
the liposomes to each sensing surface, presumably
followed by spontaneous fusion of the liposomes to
Fig. 1. NTA-DTDA mixes uniformly with membrane carrier
lipids, and membranes containing NTA-DTDA bind hexahisti-
dine-tagged proteins. Planar lipid bilayers containing either
DMPC as control (A), or DMPC plus either 2 mol% NTA-
DTDA (B), or 25 mol% NTA-DTDA (C), were deposited on
the glass slides and incubated for 30 min at 30‡C. After the in-
cubation the membranes were incubated with biotinylated B7.1-
6H protein, stained with streptavidin^FITC, and examined for
FITC-£uorescence by confocal £uorescence microscopy. The
images show the £uorescence due to binding of the B7.1-6H to
the NTA-DTDA; the £uorescence is uniformly distributed up
to a resolution of V0.1 Wm, re£ecting an even distribution of
NTA-DTDA in the membrane. Similar results were obtained
when POPC was used instead of DMPC as the carrier lipid,
and when membranes were incubated for 24 h (instead of 30
min) before binding tagged protein and staining with streptavi-
din^FITC (not shown).
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form planar lipid bilayers [20,23]. Binding of lipo-
some preparations to the cuvette surface was usually
complete within 5^10 min. The surfaces were then
washed with PBS followed by 10 mM NaOH (four
washes for the time indicated) to remove loosely
bound/unfused liposomes, before again replacing
the contents of the cuvette with PBS; after this a
stable trace was obtained giving a biosensor signal
of approximately 1750 arc s for both the B-POPE-
and the NTA-DTDA-containing membranes (see
Fig. 2A).
The biosensor data in Fig. 2A also show that sub-
Fig. 2. Deposition of NTA-DTDA-containing membranes onto IAsys biosensor cuvettes. IAsys biosensor cuvettes were cleaned (as de-
scribed in Section 2) before adding a suspension of liposomes containing either DMPC plus 2 mol% B-POPE (dotted line), or DMPC
plus 10 mol% NTA-DTDA (solid line), to the separate cells of an IAsys biosensor dual-cell cuvette. Each line represents the biosensor
trace due to binding of either lipid or protein to the sensing surface as monitored with the biosensor. After the initial membrane dep-
osition due to addition of liposomes for the time indicated by the solid bar (indicated Lipid), both cells were then washed 4^5 times
with PBS, and PBS was left in each cell. Subsequent additions made to both cells were: NaOH (10 mM), 6His-peptide (5 WM, indi-
cated 6-His), imidazole (200 mM, indicated Imid), B7.1-6H (150 nM), and streptavidin (2 WM, indicated Strept), each for the time as
indicated by the solid bars. After each addition the contents of the cuvette was aspirated and each cell washed 4^5 washes with PBS,
with PBS being left in each cell until aspirated before the next indicated addition. The trace is a representative obtained from three
separate experiments.
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sequently, the addition of 6His-peptide (5 WM) ex-
hibited little if any binding to the B-POPE-mem-
brane (dotted line), but exhibited signi¢cant binding
(V165 arc s) to NTA-DTDA-membrane (solid line).
Furthermore, binding of 6His peptide to the NTA-
membrane was saturable, and no signi¢cant dissoci-
ation occurred after replacing the contents of the
cuvette by washing four times with PBS. Bound
6His peptide could be removed completely, however,
by washing with 200 mM imidazole which is known
to compete with the interaction of histidines with
Ni2-NTA (see Fig. 2A). Similarly, the addition of
150 nM B7.1-6H (for the time indicated) also re-
sulted in signi¢cant binding to the NTA-DTDA-
membrane (biosensor signal V320 arc s), with little
dissociation occurring upon washing the membrane
with PBS, but complete dissociation upon washing
with 200 mM imidazole (Fig. 2B). The speci¢city of
the interaction of B7.1-6H with the NTA-DTDA-
membrane can be seen from the fact that the addi-
tion of 2 WM streptavidin which bound extensively
(V920 arc s) to the B-POPE-membrane, showed lit-
tle if any binding to the NTA-DTDA-membrane
(Fig. 2B). The nonspeci¢c binding of 6His peptide
and B7.1-6H to the B-POPE-membrane, and of
streptavidin to the NTA-DTDA-membrane was gen-
erally very low, and typically 6 5% of the speci¢c
binding to their respective membranes. As expected,
binding of streptavidin to the B-POPE-membrane
was stable and una¡ected by washing with imidazole
(Fig. 2B). Importantly, many successive cycles of
binding and removal of hexahistidine tagged proteins
from the NTA-DTDA-membranes (with 200 mM
imidazole) could be carried out on the same mem-
brane (over 1^2 days), with often only a slight de-
crease in the ability to bind hexahistidine-tagged pro-
teins (decrease typically 6 1^2% per cycle).
Interestingly, under these conditions active re-load-
ing of the NTA-DTDA with Ni2 was apparently
unnecessary, as 5^7 washes with PBS (over 5 min)
following the washings with imidazole was su⁄cient
to restore binding of tagged proteins to near-maxi-
mal level (not shown). These results indicate that
membranes formed on the IAsys surface from lipo-
somes exhibit good stability, and that the interaction
of hexahistidine-tagged proteins with NTA-DTDA-
containing membranes can be studied with the IAsys
biosensor.
3.3. Binding constants for the interaction
of hexahistidine-tagged proteins with
NTA-DTDA-membranes
To better characterise the strength and nature of
the interaction between hexahistidine tagged proteins
and NTA-DTDA, the binding of hexahistidine-
tagged proteins to NTA-DTDA-membranes was ex-
Fig. 3. Kinetics of the binding of hexahistidine-tagged proteins
to NTA-DTDA containing membranes. Membranes containing
either DMPC or DMPC plus 10 mol% NTA-DTDA were de-
posited in the separate cells of an IAsys biosensor cuvette. Both
cells were then washed with distilled water to remove loosely
bound liposomes, and the system was equilibrated in PBS for
5^10 min before adding B7.1-6H at the indicated concentration
in the range of 10 nM to 1 WM. The binding and dissociation
phase of the interaction of the B7.1-6H with the NTA-DTDA-
membrane were each monitored for 5 min with the biosensor,
and the binding pro¢le obtained at each concentration is shown
in A. The value of kobs for the binding curve for each concen-
tration of B7.1 was obtained using the linearisation method
(Fast Fit program) and each value was plotted against the con-
centration of protein as shown (B). A plot of kobs against pro-
tein concentration is also shown (B) for similar experiments
performed using EPOR-6H instead of B7.1-6H. For each pro-
tein the plot of kobs against protein concentration gives a
straight line; the slope represents kon, the koff for the interac-
tions were determined from the dissociation phase (see text).
Error bars show the S.E.s obtained from three separate experi-
ments at each concentration of protein.
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amined at a range of di¡erent protein concentrations.
Membranes containing 10 mol% NTA-DTDA were
deposited onto the IAsys sensing surface (as above)
and after a 5^10-min equilibration period the indi-
cated concentration of B7.1-6H (in the range of 10^
1000 nM) was added to the cuvette, and binding to
the membrane was monitored with the biosensor for
5 min; the contents of the cuvette were then replaced
by washing 4 times with PBS, and the dissociation
phase was then monitored for 5 min. Di¡erence plots
for the binding (and dissociation) of di¡erent concen-
trations of B7.1-6H to NTA-DTDA-membranes as
monitored using the IAsys biosensor are overlaid in
Fig. 3A. It can be seen that binding of B7.1-6H to
the NTA-DTDA-membrane is concentration-depen-
dent and exhibits saturation kinetics with near-max-
imal binding occurring at 1 WM B7.1-6H. Under
these conditions no signi¢cant binding of B7.1-6H
to the control DMPC membrane could be detected
(not shown). An analysis of the binding pro¢le for
each concentration of B7.1-6H using the Fast Fit
program indicated that the binding data could gen-
erally be ¢tted to a single exponential expression.
While some deviation from the single exponential
was seen at protein concentrations s 200 nM (pre-
sumably re£ecting re-binding and/or complex bind-
ing events) these deviations were relatively small and
were considered not to signi¢cantly a¡ect estimates
of the binding constants. A plot of the observed rate
constants (kobs, s31) against the concentration of
B7.1-6H approximated a straight line (see Fig. 3B)
with the line of best ¢t revealing that B7.1-6H binds
to these NTA-DTDA membranes with an on-rate
(kon) of 2.87 þ 0.06U104 M31 s31 (slope of the plot),
and an o¡-rate (koff )V1033 s31 (intercept with the
y-axis). According to the manufacturer, however, koff
values in the range 1033^1035 s31 need to be deter-
mined from the dissociation phase. Therefore, for
each B7.1 concentration the koff was determined by
extrapolating the dissociation data to the base line by
¢tting to an exponential decay curve using the Fast
Fit program (not shown). The results show that koff
for the interaction of B7.1-6H with the NTA-DTDA
membrane under these conditions was concentra-
tion-dependent, and was 0.8 þ 0.3U1034 s31 and
7.8 þ 1.2U1034 s31, at the B7.1-6H concentration
of 10 nM and 1 WM, respectively. The corresponding
apparent dissociation constants as determined using
the expression Kd = koff /kon were 2.8 þ 1.2 nM and
27 þ 5 nM, respectively. Intermediate values of koff
and Kd were obtained for B7.1-6H concentrations
between 10 nM and 1 WM (see Table 1). By compar-
ison, a determination of the Kd by Scatchard analysis
(not shown) of the equilibrium binding data, showed
that the dissociation constant for the interaction of
B7.1-6H with membranes containing 10 mol% NTA-
DTDA was 48 þ 7 nM.
Analogous studies also were carried out using a
di¡erent hexahistidine-tagged protein, EPOR-6H.
Binding and dissociation pro¢les for the interaction
of di¡erent concentrations of EPOR-6H with mem-
branes containing 10 mol% NTA-DTDA were ob-
Table 1
Preliminary binding constants for the interaction of hexahisti-
dine-tagged proteins with membranes containing NTA-DTDA
[Protein]
(nM)
kon
(M31 s31)U104
koff
(s31)U1034
Kd (nM)
B7.1-1 2.87 þ 0.06
10 0.8 þ 0.3 2.8 þ 1.2
50 2.3 þ 0.6 7.8 þ 2.2
100 3.8 þ 0.2 13.2 þ 1.0
300 5.4 þ 0.4 18.8 þ 1.9
1000 7.8 þ 1.2 27 þ 5
EPOR-6H 3.88 þ 0.15
10 2.2 þ 0.4 5.7 þ 1.2
50 3.6 þ 0.2 9.3 þ 0.9
100 6.1 þ 0.3 15.7 þ 1.4
300 10.8 þ 0.4 27.8 þ 2.1
1000 16.8 þ 1.1 43 þ 5
Experiments were performed by depositing membranes contain-
ing the carrier lipid DMPC plus 10 mol% NTA-DTDA onto
the sensing surface of an IAsys biosensor cuvette, and then
adding tagged protein (either B7.1-6H or EPOR-6H) to the ¢-
nal indicated concentration in PBS. The interaction of each
protein (at the indicated concentration) with the membrane was
monitored with the IAsys biosensor (binding and dissociation
each monitored for 5 min) as described in the legend to Fig. 3,
and the kinetic constants then determined by applying the Fast
Fit program to the binding data (see text). The on-rate (kon)
for the interaction of each protein with the membrane was de-
termined from the slope of a plot of the observed binding rate
constants against concentration (which approximated a straight
line) ; o¡-rates (koff ) were determined directly from the dissocia-
tion phase of the interaction at the indicated protein concentra-
tion. The apparent dissociation constant (Kd) at each concentra-
tion was then determined using the relationship Kd = koff /kon.
Each constant represents the mean þ S.E.M. obtained from
three independent experiments.
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tained as for B7.1-6H (not shown), and the observed
rate constants (obtained by analysis of the binding
data using the Fast Fit program) were plotted
against the EPOR-6H concentration and were found
to approximate a straight line (see Fig. 3B). The
results indicate a kon of 3.88 þ 0.15U1034 M31 s31
and a koffV1033 s31, for this interaction. As previ-
ously, koff was determined by extrapolating the dis-
sociation data to the base line by ¢tting to an expo-
nential decay curve using the Fast Fit program. The
analyses showed that the o¡-rate increased with
increasing protein concentration giving koff values
of 2.2 þ 0.4U1034 s31 and 16.8 þ 1.1U1034 s31, for
EPOR-6H concentrations of 10 nM and 1 WM, re-
spectively. The apparent dissociation constants deter-
mined using the expression Kd = koff=kon were
5.7 þ 1.2 nM and 43 þ 5 nM, respectively. As shown
in Table 1, intermediate values of koff and Kd were
obtained for EPOR-6H concentrations between 10
nM and 1 WM. A determination of Kd for this inter-
action by Scatchard analysis (not shown) of equilib-
rium binding data, revealed a Kd of 58 þ 12 nM.
3.4. E¡ect of the density of NTA-DTDA in the
membrane
The ¢nding that the o¡-rate of the interaction of
hexahistidine tagged proteins with NTA-DTDA
membranes is dependent on the concentration of
protein used during the binding phase, suggested
that the o¡-rate also could depend on the density
of NTA-DTDA in the membrane. Experiments
were carried out, therefore, to study the binding of
the hexahistidine-tagged proteins to membranes con-
taining di¡erent ratios of NTA-DTDA to the carrier
lipid DMPC. Biosensor pro¢les for the binding of
100 nM B7.1-6H to membranes containing 2, 5, 10
and 25 mol% NTA-DTDA are shown in Fig. 4. In
these experiments binding was monitored for 10 min
after addition of 100 nM B7.1-6H, before replacing
the contents of the cuvette with PBS and monitoring
the dissociation phase; the dissociation was moni-
tored for V40 min to permit a more accurate deter-
mination of the o¡-rate of each interaction. The on-
rates, as obtained from the slope of the plot of the
observed rate constant against protein concentration
(as described above) were found to decrease, while
the extent of total binding was found to increase,
with increasing NTA-DTDA in the membrane (see
Table 2). The o¡-rates were obtained by extrapolat-
ing the dissociation data to the baseline using the
Fast Fit program. Interestingly, the analysis showed
that under these conditions the dissociation phase
was best described by two dissociation components:
Fig. 4. Binding of hexhistidine-tagged proteins to membranes containing di¡erent densities of NTA-DTDA. Membranes containing ei-
ther DMPC (control) or DMPC plus the indicated concentration of NTA-DTDA (2, 5, 10 or 25 mol%) were deposited into separate
cells of an IAsys biosensor cuvette. After equilibration of the system in PBS and equilibration of the biosensor base line, 100 nM of
B7.1-6H was added to each cell and binding of the protein to the membrane was monitored for 10 min; each cell was then washed
¢ve times with PBS and the dissociation phase was monitored for approximately 45 min. There was only minimal binding of protein
to the cell containing the control membrane. The biosensor traces show the di¡erence plot for binding of the protein to membranes
containing the indicated molar ratio of NTA-DTDA. The dotted trace shows the binding and dissociation of 100 nM B7.1-6H when
bound for 2 min. Similar experiments were performed using EPOR-6H instead of B7.1-6H (not shown). Results for determination of
kinetic constants obtained from these studies are summarised in Table 2. Each trace is representative of those obtained from three ex-
periments.
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one having a relatively fast o¡-rate
(koff sV1U1033), and the other having an o¡-rate
often one to two orders of magnitude lower. A sum-
mary of the on-rates, o¡-rates, the contribution or
extent of each binding component, the stability or
half-life (t1=2), and apparent dissociation constants
for the interaction of B7.1-6H with membranes con-
taining di¡erent molar ratios of NTA-DTDA to
DMPC is shown in Table 2. The results indicate
that the highest koff values [being 68 þ 8U1034 s31
(fast) and 12 þ 3U1034 s31 (slow) and re£ecting the
least stable binding or shortest t1=2] occur with mem-
branes containing 2 mol% NTA-DTDA; whereas the
lowest koff values [being 7.7 þ 0.9U1034 (fast) and
0.11 þ 0.02U1034 (slow) and re£ecting the most sta-
ble binding (t1=2V17 h for slow component)], occur
with membranes containing 25 mol% NTA-DTDA.
The apparent dissociation constants also re£ect a
much tighter binding occurring at higher NTA-
DTDA densities: thus, at 2 mol% NTA-DTDA the
constants were 190 þ 28 nM for Kdfast and 33 þ 9
nM for Kdslow, whereas at 25 mol% NTA-DTDA
these constants were 31 þ 4 nM for Kdfast and
0.4 þ 0.1 nM for Kdslow. Membranes containing
5 and 10 mol% NTA-DTDA gave intermediate val-
ues of the binding constants (see Table 2).
In analogous experiments we also examined the
binding of EPOR-6H to membranes of di¡erent
NTA-DTDA densities; these data are also summa-
rised in Table 2 for comparison. Similar to B7.1-6H,
the results show that for EPOR-6H the slowest o¡-
rates, being 29 þ 1U1034 s31 (fast) and
1.1 þ 0.1U1034 s31 (slow), are seen with the highest
NTA-DTDA concentration (25 mol%). O¡-rates for
Table 2
Binding constants for the interaction of hexahistidine-tagged proteins with membranes containing di¡erent densities of NTA-DTDA
Protein NTA-DTDA
(mol%)
kon (M31 s31)U104 koff (s31)U1034 Extent
(arc s þ 15%)
t1=2 (min) Kd (nM)
B7.1-6H
2 3.60 þ 0.12 68 þ 8 (fast) 11 1.7 þ 0.2 190 þ 28
12 þ 3 (slow) 17 9.6 þ 2.4 33 þ 9
5 3.25 þ 0.09 32 þ 2 (fast) 70 3.6 þ 0.2 98 þ 9
2.8 þ 0.7 (slow) 95 41 þ 10 8.6 þ 2.5
10 2.87 þ 0.06 20 þ 1 (fast) 101 5.8 þ 0.3 70 þ 5
0.46 þ 0.05 (slow) 165 251 þ 27 1.6 þ 0.2
25 2.52 þ 0.07 7.7 þ 0.9 (fast) 63 15 þ 2 31 þ 4
0.11 þ 0.02 (slow) 420 1050 þ 190 0.4 þ 0.1
EPOR-6H
2 4.67 þ 0.24 141 þ 11 (fast) 20 0.8 þ 0.1 302 þ 38
30 þ 6 (slow) 12 3.8 þ 0.8 64 þ 16
5 4.03 þ 0.18 70 þ 4 (fast) 44 1.7 þ 0.1 174 þ 17
4.6 þ 1.1 (slow) 36 25 þ 6 12 þ 3
10 3.88 þ 0.26 45 þ 2 (fast) 71 2.6 þ 0.1 116 þ 13
2.9 þ 0.3 (slow) 68 40 þ 4 7.5 þ 1.4
25 3.57 þ 0.10 29 þ 1 (fast) 140 4.0 þ 0.1 81 þ 5
1.1 þ 0.1 (slow) 265 105 þ 9 3.1 þ 0.4
Experiments were performed by depositing membranes containing the carrier lipid DMPC plus the indicated densities of NTA-DTDA
(expressed as mol%) onto the sensing surface of an IAsys biosensor cuvette, and then adding 100 nM of the indicated tagged protein
(either B7.1-6H or EPOR-6H) in PBS (pH 7.4) to the cuvette also containing PBS. The binding and dissociation phase of the interac-
tion of each protein with the membrane containing the indicated percentage of NTA-DTDA was monitored with the biosensor for 10
and 40 min, respectively, exactly as described in the legend to Fig. 4; and the kinetic constants then determined by applying the Fast
Fit program to the binding data (see text). The on-rates (kon) were determined from data obtained from an analysis of the binding of
di¡erent concentrations of each protein with membranes containing the indicated percentage of NTA-DTDA; o¡-rates (koff ) were de-
termined from the dissociation phase of the indicated interaction by ¢tting to a double-exponential model which calculated the koff
and dissociation extent for the fast and slow dissociation reactions. The apparent dissociation constant (Kd) for each interaction was
then determined using the relationship Kd = koff /kon. Each constant represents the mean þ S.E.M. obtained from three independent ex-
periments.
BBAMEM 78113 9-7-01
J.G. Altin et al. / Biochimica et Biophysica Acta 1513 (2001) 131^148142
EPOR-6H were generally about 2-fold faster, result-
ing in V2-fold higher Kd values compared to those
for B7.1-6H (see Tables 1 and 2). Additional experi-
ments also showed that for membranes containing 25
mol% NTA-DTDA, the greatest proportion of stably
bound protein occurred when B7.1-6H and EPOR-
6H were initially bound at low concentrations
(6 100 nM) and levels of 6 200^300 arc s (see dot-
ted trace in Fig. 4). Under these conditions very little
if any dissociation of either B7.1-6H or EPOR-6H
from the membrane could be detected; any dissocia-
tion was typically 6 2% of the total amount of pro-
tein initially bound, and occurred only during the
¢rst 5^10 min of replacing the contents of the cuvette
with PBS. Thereafter, no signi¢cant dissociation
could be detected during the period being monitored
(V40 min), even when the cuvette was washed peri-
odically with PBS to remove any dissociated protein
(not shown).
3.5. Binding of erythropoietin to its receptor anchored
to membranes via NTA-DTDA
To determine whether NTA-DTDA-membranes
can be used in applications to study ligand^receptor
interactions on the IAsys biosensor, we investigated
the binding of the haematopoietic growth factor
erythropoietin (EPO) to its receptor (EPOR-6H) an-
chored onto the membrane. To maximise stability of
the anchored EPOR-6H, membranes containing 25
mol% NTA-DTDA were deposited onto an IAsys
cuvette and both the EPOR-6H in the test cell, and
B7.1-6H in the control cell, were bound at a protein
concentrations of 100 nM. Typical experiments to
assay for EPO binding were carried out with V150
arc s of bound EPOR-6H in the test cell and control
protein (B7.1-6H) in the control cell. After addition
and binding of the EPOR-6H and B7.1-6H proteins
to the NTA-DTDA-membranes, each cell was
washed a total of 10^12 times with PBS over an
equilibration period of 5^10 min, to remove any
loosely bound protein. Under these conditions the
bulk of the bound proteins (s 99%) were stably
bound. When a stable baseline was achieved, di¡er-
ent concentrations of EPO (ranging from 0.5 nM to
20 nM) was added to the cells, and binding of solu-
ble EPO was monitored with the biosensor for 5 min
(see Fig. 5A). The contents of both cells was then
replaced by washing with PBS (four washes) before
monitoring the dissociation phase for 5 min. Since it
was not possible to remove bound EPO from the
EPOR-6H without removal of the EPO-EPOR-6H
complex from the NTA-DTDA-membrane, the bind-
ing and dissociation at each EPO concentration was
followed by an imidazole wash cycle (not shown) to
Fig. 5. Binding of soluble human EPO to EPOR-6H anchored
onto NTA-DTDA membranes. Membranes containing 25 mol%
NTA-DTDA were deposited into each cell of an IAsys 2-cell
cuvette as detailed in the legend to Fig. 4. EPOR-6H and B7.1-
6H (each at 100 nM) were then added to the test cell and con-
trol cell, respectively, to give a level of V150 arc s of bound
protein in each cell. After 10^12 washes with PBS over 5^10
min and equilibration of the baseline, soluble human EPO at
concentrations ranging from 0.5 to 20 nM was then added to
both cells and the binding of the EPO to each cell was moni-
tored for 5 min, before washing with PBS and monitoring the
dissociation phase for 5 min. Di¡erence plots for the binding of
the indicated concentrations of EPO to the EPOR anchored on
the NTA-DTDA-membrane are shown overlaid in A. The value
of kobs for the binding curve for each concentration of EPO
was obtained using the linearisation method (Fast Fit program)
and plotted against the EPO concentration (B); the plot ap-
proximates a straight line with the slope representing kon and
the y-intercept representing koff for this interaction. Error bars
show the S.E.s obtained from three or four separate experi-
ments at each concentration of protein.
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remove all EPO^EPOR complexes from the mem-
brane, before again binding EPOR-6H (or control
protein) to the membrane, and monitoring binding
at a di¡erent concentration of EPO. As shown in
Fig. 5A, the binding of EPO to the EPOR was found
to be concentration-dependent and saturable; the
binding being just detectable at 0.5 nM, and near-
maximal at V10 nM EPO. From the extent of max-
imum EPO binding at saturation, the stoichiometry
of the EPO/EPOR interaction was determined to be
1:2. The plot of the observed rate constant (as de-
termined from the binding data using the Fast Fit
program) against EPO concentration is shown in
Fig. 5B and approximates a straight line. From this
data the on-rate, o¡-rate and dissociation constant
for the EPO^EPOR interaction were found to be
1.6 þ 0.2U106 M31 s31, 2.8 þ 0.4U1033 s31, and
1.7 þ 0.5 nM, respectively. By comparison, the disso-
ciation constant as determined from equilibrium
binding data (not shown) was 2.8 þ 1.2 nM.
4. Discussion
This paper describes the synthesis of the chelator
lipid NTA-DTDA, and demonstrates its use to an-
chor hexahistidine-tagged proteins onto model mem-
brane systems for the study of molecular interactions
with optical biosensors. Initial studies showed that
lipid mixtures containing NTA-DTDA are readily
dispersed by sonication in aqueous media to form a
suspension suitable for deposition of planar mem-
branes on hydrophilic supports. Membranes contain-
ing NTA-DTDA and a carrier lipid, either DMPC or
POPC, were examined by £uorescence microscopy
since the technique is reported to be capable of re-
solving individual inhomogeneities or patches of lipid
when labelled with a £uorochrome on bilayers [6,8].
NTA-DTDA-containing membranes incubated with
a hexahistidine-tagged protein (e.g., biotinylated
B7.1-6H) and then stained with streptavidin^FITC,
showed increased £uorescence compared to control
DMPC or POPC membranes, but no regions of
phase-separated NTA-DTDA could be detected
even in mixed bilayers incubated for V16 h at a
temperature sTm of the carrier lipid. This ¢nding
suggests ¢rstly, that NTA-DTDA binds hexahisti-
dine-tagged proteins, and secondly, that within the
level of resolution provided by the technique (V0.1
Wm), the NTA-DTDA is miscible with both DMPC
and POPC, and does not phase-separate. This con-
clusion is consistent with X-ray di¡raction studies
with chelator lipids possessing longer carbon chains
[5,6], and also with preliminary X-ray di¡raction
studies of NTA-DTDA/DMPC phases (F.A.J.
White, S.T. Hyde, J.G. Altin, unpublished observa-
tions).
Optical biosensors represent a relatively novel ap-
proach to study biomolecular interactions, with the
two most common implementations of the technique
being the BIAcore surface plasmon resonance bio-
sensor, and the IAsys resonant mirror biosensor.
To explore the potential for lipid mixtures containing
NTA-DTDA to form stable membranes for the
study of protein^protein interactions, the present
work employed an IAsys biosensor with a dual-cell
hydrophobic cuvette. Initial attempts to deposit lipid
membranes on IAsys hydrophobic cuvettes from a
solution of lipids in organic solvents did not always
produce consistent results, even when the procedure
was carried out according to IAsys protocols. This
was attributed to an incomplete regeneration and/or
reduced hydrophobicity of the sensing surface. In
view of the cost of IAsys cuvettes several di¡erent
cleaning methods were tested to see if reproducible
membrane depositions could be achieved. The most
successful approach entailed successive treatments or
washes of the cuvette with ethanol, NaOH, HCl and
water (see Section 2). This treatment completely re-
moved the hydrophobic surface layer of the cuvette,
but produced a surface which was highly hydrophilic,
and permitted a rapid deposition of bilayer mem-
branes from liposomes. Importantly, membranes de-
posited in this way were stable (for several days), and
could be used for many cycles of binding and disso-
ciation of tagged proteins from the membrane. Inter-
estingly, a similar treatment applied to amino silane
IAsys cuvettes also produced a surface suitable for
reproducible membrane deposition; however, be-
cause amino silane cuvettes are designed for com-
plete aspiration of the contents upon washing, use
of these cuvettes required adjustments to ensure
that the membrane was not damaged mechanically
by the stirrer or directly exposed to air upon aspira-
tion of the cuvette contents (not shown). Bilayer
membranes deposited on both types of IAsys cu-
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vettes prepared in this way always gave the expected
symmetrical resonance scan, indicating that mem-
brane coverage was uniform and that the instrument
could generate a reliable biosensor signal. A major
advantage of this approach is that each IAsys cuvette
could be re-used in some 30^50 separate membrane
depositions, provided that freshly prepared lipo-
somes were used, and that each deposition was pre-
ceded by the ethanol-NaOH-HCl wash cycle.
IAsys biosensor experiments with NTA-DTDA-
containing membranes indicated these membranes
speci¢cally bind hexahistidine-tagged proteins, but
that the binding and stability of the bound protein
is dependent on the density of NTA-DTDA in the
membrane, the concentration of protein used during
binding phase, and on the total amount of protein
deposited (Figs. 3 and 4). Theoretical considerations
would suggest that each Ni2-NTA-headgroup can
interact simultaneously with only two histidines,
and therefore that a hexahistidine tag can bind up
to three NTA-headgroups. It can be expected, there-
fore, that hexahistidine-tagged protein would bind
initially to one NTA-headgroup, and then bind to
neighbouring NTA headgroups, with the most stable
binding occurring when each hexahistidine tag can
interact simultaneously with three NTA-headgroups.
The interaction of hexahistidine-tagged proteins with
chelator lipids like NTA-DTDA is thus complex, and
a complete analysis of the nature and kinetics of the
interaction was considered beyond the scope of the
present work. However, our use of single- and dou-
ble-exponential curve ¢tting to determine the appar-
ent dissociation constants suggests a general model
for the interaction of hexahistidine tagged proteins
with NTA-DTDA membranes.
The binding of B7.1-6H and EPOR-6H to NTA-
DTDA-membranes was saturable with maximum
binding occurring at a concentration of V1 WM;
for membranes containing 25 mol% NTA the on-
rate of the interaction was 2.52 þ 0.07U104 M31 s31
and 3.57 þ 0.10U1034 M31 s31, for B7.1-6H and
EPOR-6H, respectively (Fig. 3 and Table 1). The
fact that the binding phases could be accurately de-
scribed by a single exponential ¢t suggests that the
binding reaction has only a single rate-limiting step,
and that once a hexahistidine tag binds to one Ni2-
NTA headgroup, it can quickly bind to other nearby
headgroups, if available. This notion is supported by
the observation that the protein deposited onto a 25
mol% NTA-DTDA membrane during the ¢rst 2 min
of incubation (extent V250 arc s) exhibited negli-
gible dissociation whereas protein deposited in the
subsequent 8 min (V250 arc s) exhibited a fast dis-
sociation component with an extent of approxi-
mately 63 arc s (Fig. 4). This suggests that protein
deposited onto membranes with high levels of NTA-
DTDA is initially able to bind strongly up to three
Ni2-NTA headgroups, but protein deposited later
may only be able to bind one or two, and so corre-
spondingly exhibit faster dissociation (see below).
Although on-rates were 25^33% higher for mem-
branes containing 2 mol% NTA-DTDA, under these
conditions the extent of B7.1-6H and EPOR-6H
binding was only a fraction (V10%) of that occur-
ring at 25 mol% NTA-DTDA (see Table 2). These
observations are consistent with faster saturation of
the fewer available Ni2-NTA headgroups at 2 mol%
NTA-DTDA.
An analysis of the dissociation phase of the inter-
action of B7.1-6H and EPOR-6H with NTA-DTDA
membranes using the Fast Fit software indicated that
under these conditions each dissociation phase could
be described by at least two components, one having
a relatively fast o¡-rate (V1033 s31), and a second
having 10^100-fold slower o¡-rate, with the slower
o¡-rate component clearly dominating (i.e., greater
extent of binding) at the highest NTA-DTDA mem-
brane densities. The fact that the dissociation phases
could be more accurately described by a double ex-
ponential ¢t of fast and slow dissociating compo-
nents suggests that these components represent hexa-
histidine-tagged protein bound weakly to one or two,
or strongly to three Ni2-NTA headgroups, respec-
tively. Membranes containing 25% NTA-DTDA
gave the most stable binding of B7.1-6H with o¡-
rates of 7.7 þ 0.9U1034 s31 (fast) and 0.11 þ
0.02U1034 s31 (slow) with apparent dissociation
constants of 31 and 0.4 nM, respectively. The o¡-
rates increased to 68 þ 0.9U1034 s31 (fast) and
12 þ 0.02U1034 s31 (slow) for membranes containing
2 mol% NTA-DTDA (Table 2). It is not clear
whether the variation in o¡-rates with NTA-DTDA
densities is due to di¡erent levels of available NTA-
DTDA, or of incompletely bound protein-NTA-
DTDA intermediates. Nonetheless, the kinetic con-
stants found above are in good agreement with pub-
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lished data for the interaction of hexahistidine-
tagged proteins with NTA [10,27,28]. Our ¢ndings
also are consistent with the observations that at
low NTA densities (V2%) the binding of hexahisti-
dine-tagged proteins can be described by a ¢rst order
model, but that at higher NTA densities (s 10%)
cooperative multivalent binding events occur, result-
ing in high avidity binding and a ‘trapping’ of the
proteins at the membrane surface [10,28].
An alternative explanation for the apparently sta-
ble binding B7.1-6H is that at higher NTA-DTDA
densities the rate of re-binding of any dissociated
protein is higher, thereby reducing the apparent o¡-
rate. Although re-binding may contribute to the
stability of the hexahistidine-tagged proteins bound
to NTA-DTDA membrane in this system, the fact
that we could not detect any signi¢cant increase in
dissociation upon increasing the stirring rate of the
bu¡er in the cuvette or after repeated washing of the
cuvette with PBS to remove any dissociated protein
(not shown), suggests that under these conditions re-
binding contributes at most minimally to the stability
of the NTA-DTDA anchored hexahistidine-tagged
proteins. The results therefore are consistent with
stable binding of hexahistidine-tagged proteins to
NTA-DTDA-membranes being largely dependent
on the availability of NTA-headgroups on the mem-
brane, in order that each hexahistidine tag is able to
interact simultaneously with multiple (two or three)
NTA-headgroups (as discussed above).
The interaction of EPOR-6H with NTA-DTDA-
membranes displayed a similar pattern to that of
B7.1-6H, but EPOR-6H generally exhibited about
twice the o¡-rate, and a correspondingly lower ap-
parent binding a⁄nity (see Table 2). As reported for
the binding of hexahistidine-tagged proteins to NTA-
headgroups covalently immobilised onto biosensor
surfaces [29,30], the observed di¡erences in the abil-
ity of these proteins to interact with NTA-DTDA
membranes are likely to be due to characteristic dif-
ferences in protein structure which may sterically
hinder the hexahistidine tag from interacting with
NTA-headgroups.
Of especial note is fact that for both B7.1-6H and
EPOR-6H no signi¢cant dissociation of membrane-
bound protein could be detected (koff 6 1U1034),
when proteins were bound both at low concentra-
tions, and at low levels, to membranes containing
25 mol% NTA-DTDA (Fig. 4). This suggests that
under these conditions the interaction of hexahisti-
dine-tagged proteins with NTA-DTDA membranes
has high stability (t1=2s 10^20 h). This attribute
makes the chelator lipid useful in biosensor applica-
tions for the study of the interaction of anchored
receptors with soluble ligands.
The present study also demonstrates that mem-
branes containing NTA-DTDA can be used to study
receptor^ligand interactions, as exempli¢ed by an
analysis of the binding of EPO to the EPO receptor.
The EPOR is known to consist of a 100 kDa trans-
membrane protein with the ligand binding site being
situated on domain 2 of the extracellular region of
the receptor [31^33]. The binding of erythropoietin
and concomitant stabilisation of EPOR-dimers is
thought to form an essential component of the trans-
membrane signalling mechanism of the receptor, but
it is unclear whether EPO binds ¢rst to the mono-
meric receptors or whether EPO binds to pre-formed
dimers [34,35]. In the present work a recombinant
form of the human EPOR comprising the extracellu-
lar region of the receptor with a hexahistidine tag at
its carboxyl terminal (EPOR-6H) was produced and
expressed in the baculovirus expression system, and
the puri¢ed protein then bound to NTA-DTDA
membranes in experiments to study the interaction
of soluble EPO with the membrane-bound EPOR-
6H using the IAsys biosensor. To promote stable
binding of the EPOR-6H to the membrane these
studies were carried out with membranes containing
25 mol% NTA-DTDA; and the EPOR-6H was
bound at low concentrations (6 100 nM) and at rel-
atively low levels (V150 arc s). Under these condi-
tions the binding of soluble EPO to its receptor on
the membrane was readily detectable using this sys-
tem (see Fig. 5A). The binding of soluble EPO was
concentration-dependent and saturable; the on-rate,
o¡-rate and dissociation constant for the EPO^
EPOR interaction were found to be 1.6 þ 0.2U106
M31 s31, 2.8 þ 0.4U1033 s31, and 1.7 þ 0.5 nM, re-
spectively (Fig. 5B). In addition, the stoichiometry of
the interaction was determined to be 1 EPO:2
EPOR. These ¢ndings are consistent with reported
values for the binding constants and models for the
EPO^EPOR interaction [33^37]. To our knowledge
this is the ¢rst demonstration that a recombinant
form of the human extracellular region of the
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EPOR possessing a hexahistidine tag is able to bind
EPO, and further, that a chelator-lipid membrane
system (utilising NTA-DTDA) can be used to study
the interaction between soluble EPO and recombi-
nant EPOR-6H anchored to a membrane. By mod-
ulating the £uidity of the membrane (e.g., by chang-
ing the temperature or using lipids with a di¡erent
Tm) and hence a¡ecting the ability of membrane-
bound receptors to move and dimerise, we envisage
that such a system could potentially be useful for
investigating the mechanism of EPOR binding and
dimerisation.
In summary, this paper reports the synthesis of the
chelator lipid, NTA-DTDA, and demonstrates that it
can be used with the IAsys biosensor to study the
interaction of soluble ligands with proteins anchored
onto a membrane on the biosensor surface. A clear
advantage of this approach is that receptors are an-
chored reversibly in the correct orientation onto the
membrane, and that the molecules are free to move
and interact laterally on the membrane, potentially
permitting receptor dimerisation/oligomerisation as
well as an interaction with soluble ligand. We envis-
age that this system can mimic the physiological sit-
uation more closely than one in which the receptor
molecules are covalently immobilised onto the bio-
sensor surface. Also, the shorter carbon chain length
of NTA-DTDA (C-14) compared to NTA-DODA
(C-18) another chelator lipid in this class [10], makes
NTA-DTDA ideal for use in situations where a sta-
ble chelator lipid with lower Tm is required, either to
facilitate formation of £uid membranes or to pro-
mote fusion of chelator lipid-liposomes. Recently,
we showed that NTA-DTDA can be incorporated
into the membrane of cells for ‘engrafting’ costimu-
latory molecules onto the surface of cells, and that
such cells are active in enhancing tumour immunity
and/or eliciting responses in vivo when used as vac-
cines in animal models [19]. In addition, we recently
showed that NTA-DTDA can be used for conven-
iently anchoring targeting molecules onto liposomes
for detecting low a⁄nity receptor^ligand interactions
on cells, and for the induction of biological responses
in vivo [38]. The present work, demonstrating that
the NTA-DTDA can be used with biosensors to
study the interaction of soluble proteins with pro-
teins anchored onto a model membrane, therefore,
further supports the potential usefulness of chelator
lipids like NTA-DTDA in a wide range of biophys-
ical and biological applications.
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